TSS
OPXAW

Two Sigma Securities’s Opexa Therapeutics, Inc. OPXAW Stock Holding History

Two Sigma Securities’s Portfolio OPXAW Stock Details OPXAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-181,400
Closed -$20K – 1371
2017
Q2 		$20K Buy
+181,400
New +$6.73K ﹤0.01% 783

Two Sigma Securities's OPXAW Position: Q3 2017 in Review

Two Sigma Securities sold out of Opexa Therapeutics, Inc. (OPXAW) in Q3 2017, closing a stake of 181,400 shares — an estimated $20K sold.

Two Sigma Securities first reported a position in OPXAW in Q2 2017 and held it in 1 quarter. The position peaked at $20K in Q2 2017. 0 funds tracked by Wall St. Rank hold OPXAW as of Q3 2017.

  • Two Sigma Securities reported no remaining Opexa Therapeutics, Inc. position as of Q3 2017 after selling out during the quarter.
  • Two Sigma Securities sold 181,400 Opexa Therapeutics, Inc. shares in Q3 2017, an estimated $20K.
  • Two Sigma Securities first reported a position in Opexa Therapeutics, Inc. in Q2 2017 and held it in 1 quarter.
  • Two Sigma Securities's Opexa Therapeutics, Inc. position peaked at $20K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Opexa Therapeutics, Inc. as of Q3 2017.

Based on Two Sigma Securities's 13F filing for Q3 2017, filed 14 Nov 2017.